Entecavir With or Without Pegylated Interferon α-2b in Children Aged 3-6 Years With Immune-Tolerant Chronic Hepatitis B
Clinical trial NCT07345624 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07345624
- Sponsor
- Qing-Lei Zeng
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-11
- Primary completion
- 2030-12-31
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.